”Lasten idiopaattisen varvaskävelyn botuliinihoito – satunnaistettu kontrolloitu arvioijasokkoutettu tutkimus”
Phase 1
- Conditions
- Idiopathic toe-walkers
- Registration Number
- EUCTR2009-017308-10-FI
- Lead Sponsor
- Heli Sätilä
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Verified idiopathic toewalking
No achilles contracture
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
No surgery or casting or previous botulinum toxin injections
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To compare fysiotherapy and fysiotherapy + botulinum toxin when treating idiopathic toewalking;Secondary Objective: ;Primary end point(s): Follow-up 2 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie botulinum toxin effects in idiopathic toe-walking pediatric patients?
How does botulinum toxin compare to physical therapy for idiopathic toe-walking in randomized controlled trials?
Which biomarkers correlate with botulinum toxin response in idiopathic toe-walking clinical studies?
What adverse events are reported in phase I botulinum toxin trials for pediatric neuromuscular disorders?
Are there combination therapies or alternative neuromodulators for idiopathic toe-walking beyond botulinum toxin?